News | July 10, 2022
Capnopharm to acquire operational assets of Capnomed
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
The vaccine is under FDA review
It is a two dose vaccine to be administered intramuscularly at 28 days apart
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
Subscribe To Our Newsletter & Stay Updated
